case showed progressive enlargement with visual loss and was managed with translimbal aspiration. Symptomatic midzonal IPE cysts can be deflated with translimbal aspiration rather than more aggressive surgical excision.
the nondilated state and more elongated or fusiform following pupillary dilation. This brown-colored lesion demonstrates further elongation with further dilation, an evolving picture not seen with melanoma. These clinical features, in combination with anterior segment imaging on ultrasound biomicroscopy (UBM) and anterior segment optical coherence tomography (AS-OCT), help to differentiate midzonal IPE cyst from ciliary body melanoma. Herein, we describe a midzonal IPE cyst that enlarged over 4 years and caused loss of vision, but responded to needle aspiration deflation.
Case Report
In September 2009, a 37-year-old asymptomatic woman was referred for evaluation and management of a possible ciliary body melanoma in the left eye (OS). On our examination, visual acuity was 20/20 in each eye (OU) and intraocular pressures were normal OU. The right eye was unremarkable. The left eye demonstrated an asymptomatic, smooth, uniformly brown, rounded mass in the inferior retroiridic location simulating melanoma; however, following pupillary dilation, the mass became more fusiform and occluded the inferior one-third of the pupil (Fig. 1a ). There were no sentinel blood vessels. Imaging with UBM and AS-OCT demonstrated anterior displacement of the iris stroma by a smooth, thinwalled cyst, with no evidence of a solid mass (Fig. 1b) . A diagnosis (Fig. 1c) . Imaging with UBM and AS-OCT again confirmed a cystic structure that overhung the pupil (Fig. 1d) .
After extensive counseling, she declined surgical intervention, despite vision loss. She was prescribed phenylephrine 2.5% eye drops twice daily for 3 weeks by her local physician, with no relief. In March 2014, she complained of slight visual impairment OS, with visual acuity of 20/40 probably because of cyst encroachment into the visual axis. The intraocular pressure was normal. Examination revealed the IPE cyst now occluded about 70% of the pupillary aperture, with new plump overhang into the anterior chamber (Fig. 1e) . AS-OCT showed further extension of the cyst across the pupil (Fig. 1f) . The patient agreed to surgical intervention.
Using local retrobulbar anesthesia and the operating microscope, we passed a 30-G needle through the corneoscleral limbus inferotemporally and directed it through the cyst wall inferiorly at the pupillary margin inferiorly, avoiding the visual axis. Slow aspiration into a 10-mL syringe was performed, and the cyst promptly collapsed and disappeared behind the iris stroma.
On examination 2 months following the aspiration deflation, visual acuity was 20/20 OU, the ocular discomfort had resolved, and the cyst was not visible, even following wide dilation of the pupil (Fig. 1g) . On AS-OCT, a small remnant behind the iris stroma was observed (Fig. 1h) . The patient has remained comfortable with stable visual acuity and without cyst recurrence for 3 years following aspiration.
Discussion
In a comprehensive analysis of 3,680 iris lesions, solid tumors were found in 2,912 (79%) and cystic lesions in 768 (21%) [9] . Analysis of the various IPE cysts revealed central (7%), midzonal (28%), peripheral (63%), and freefloating/dislodged (2%) types [7, 9] . In that cohort, there were 188 eyes with stromal IPE cysts, of which 29 (15%) were those of children (0-20 years), 30 (16%) were those of young adults (21-40 years), 50 (27%) were those of mid-adults (41-60 years), and 79 (42%) were those of older adults (>61 years) [7] . Our patient was 37 years old at presentation, an age more commonly associated with peripheral (75%) rather than midzonal (12%) IPE cysts [7] .
Most midzonal IPE cysts are located posterior to the iris stroma and often not clinically visible. By meticulous slit lamp biomicroscopy, an IPE cyst is suspected if there is an anterior bulge of the otherwise normal overlying iris stroma. Following pupillary dilation, some IPE cysts are visible, including the central and midzonal types. Often, the peripheral type or dislodged lesions require further evaluation with gonioscopy to reach behind the iris stroma or into the anterior chamber angle for visualization of the cyst.
The midzonal IPE cyst is a particularly interesting lesion, since it closely simulates ciliary body melanoma, as in this case, prompting referral. A midzonal cyst can be partly visualized with a bulbous, smooth, uniform, brown surface behind the iris, quite similar to melanoma. However, midzonal IPE cysts become stretched from round to elongated following pupillary dilation. This feature, along with the lack of sentinel vessels, lack of a transillumination shadow, and imaging features of a cystic mass, serves to confirm the diagnosis. Most midzonal IPE cysts are asymptomatic and require no treatment.
This case was unusual, since most IPE cysts remain stable. Midzonal cysts classically appear unilobular or multilobular, rarely covering the visual axis or affecting visual acuity. In our case, the midzonal IPE cyst extended approximately one-third over the pupillary aperture and later enlarged to more than two-thirds the pupillary diameter, causing low-grade ocular discomfort and vision loss.
Most IPE cysts are asymptomatic and require no treatment. Occasionally, central cysts may require deflation, but this is rarely necessary for other types of cyst. In this case, needle aspiration deflation allowed for relocation of the partially subluxated lens and retention of visual acuity. This approach for a symptomatic midzonal IPE cyst can achieve rapid resolution of symptoms when compared with surgical removal, laser photocoagulation, or other methods. In summary, we described a rare midzonal IPE cyst that demonstrated enlargement and caused ocular discomfort and visual loss. It was successfully managed with aspiration deflation.
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